http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101704121-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6844 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2014-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101704121-B1 |
| titleOfInvention | Biomarker composition for discrimination of vancomycin heteroresistant Staphylococcus aureus ST5 clone type and discrimitic kit using the same |
| abstract | The present invention relates to a biomarker composition for discrimination of vancomycin heterogeneous resistant Staphylococcus aureus (hVISA) ST5 clone type comprising at least one gene mutation selected from the group consisting of spa and lpl6, and a kit for use therefor, (HVISA) ST5 clone type, and using the acquired gene mutation as a biomarker composition for hVISA ST5 clone type discrimination, the hVISA ST5 clone type The patient can be promptly and accurately treated. Also, it can be used very usefully because it can develop a hint for clone type identification of hVISA ST5. |
| priorityDate | 2014-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 257.